Alira Health

Alira Health

Alira Health was founded to bridge advisory and investment in the life sciences sector. The firm maintains a consulting practice that serves biopharmaceutical, medical device, and diagnostic companies, offering services from clinical development to market access strategy. This advisory work creates a proprietary lens into emerging technologies and unmet clinical needs, which directly informs the firm's investment decisions. The investment arm targets early-stage therapeutics, digital health platforms, and enabling technologies. Sectors include oncology, neurology, and rare disease, along with health IT and AI-driven drug discovery tools. The firm pursues direct equity positions, often participating in seed and Series A rounds, and occasionally structures revenue-based financing for commercial-stage healthcare services companies. Geographic focus spans North America and Western Europe, with a particular emphasis on innovation clusters in Boston, San Francisco, and Switzerland. Headquartered in Boston with additional offices in the United States and Europe, Alira Health maintains a team of scientists, clinicians, and former industry operators who evaluate both scientific merit and commercial viability. The firm does not publicly disclose assets under management or total deployment figures. Its consulting division operates alongside the investment function, a dual-track model that differentiates its origination from traditional venture capital firms. No adjacent philanthropic or club vehicles are publicly associated with the firm. The structural distinction lies in the interdependence of consulting and investing. Advisory engagements generate fee income while surfacing diligence insights, and portfolio companies can access the firm's regulatory and commercialization expertise. This setup allows Alira Health to compete for allocations in competitive life sciences rounds where technical evaluation is a bottleneck for generalist investors.